Phosphoramidate derivatives of d4T as inhibitors of HIV: The effect of amino acid variation

Antiviral Research

Volumn 35, Issue 3, 1997, Pages 195-204

  McGuigan, Christopher ^a   Tsang, Hing Wo ^a   Cahard, Dominique ^a   Turner, Kevin ^a   Velazquez, Sonsoles ^a   Salgado, Antonio ^a   Bidois, Laure ^a   Naesens, Lieve ^b   De Clercq, Erik ^b   Balzarini, Jan ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

2',3' Dideoxy 2',3' didehydro thymidine; HIV; Nucleotide; Phosphoramidate; Pro drug

Indexed keywords

AMINO ACID; ANTIVIRUS AGENT; NUCLEOSIDE ANALOG; PHOSPHORAMIDIC ACID DERIVATIVE; PRODRUG; STAVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

AMIDES; AMINO ACIDS; ANIMALS; CELL LINE; HIV; HIV-1; HIV-2; HUMANS; MICE; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHORIC ACID ESTERS; PHOSPHORIC ACIDS; STAVUDINE; STRUCTURE-ACTIVITY RELATIONSHIP; THYMIDINE KINASE;

EID: 0030872397     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(97)00029-6     Document Type: Article

References (22)

1. Balzarini, J., Herdewijn, P., De Clercq, E., 1989. Differential patterns of intracellular metabolism of 2′,3′-didehydro- 2′,3′-dideoxythymidine and 3′-azido-2′,3′-dideoxythymidine, two potent anti-human immunodeficiency virus compounds. J. Biol. Chem. 264, 6127-6133.
2. Balzarini, J., Holy, A., Jindrich, J., Naesens, L., Snoeck, R., Schols, D., De Clercq, E., 1993. Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: Potent and selective in vitro and in vivo antiretrovirus activities of (R)9-(2-phosphonomethoxypropyl)-2,6-diaminopurine. Antimicrob. Agents Chemother. 37, 332-338.
3. Balzarini, J., Karlsson, A., Aquaro, S., Perno, C.-F., Cahard, D., Naesens, L., De Clercq, E., McGuigan, C., 1996a. Mechanism of anti-HIV action of masked alaninyl d4TMP derivatives. Proc. Natl. Acad. Sci. USA 93, 7295-7299.
4. Balzarini, J., Egberinck, H., Hartmann, K., Cahard, D., Thormar, H., De Clercq, E., McGuigan, C., 1996b. Anti-retrovirus specificity and intracellular metabolism of 2′,3′-didehydro-2′,3′-dideoxythymidine (Stavudine) and its 5′-monophosphate triester prodrug So324. Mol. Pharmacol. 50, 1207-1213.
5. Farrow, S.N., Jones, A.S., Kumar, A., Walker, R.T., Balzarini, J., De Clercq, E., 1990. Synthesis and biological properties of novel phosphotriesters: A new approach to the introduction of biologically active nucleotides into cells. J. Med. Chem. 33, 1400-1406.
6. Girardet, J.-L., Perigaud, C., Aubertin, A.-M., Gosselin, G., Kirn, A., Imbach, J.-L., 1995. Increase of the anti-HIV activity of d4T in human T-cell culture by use of SATE pronucleotide approach. Bioorg. Med. Chem. Lett. 5, 2981-2984.
7. Gosselin, G., Imbach, J.-L., 1993. The anti-HIV nucleoside phosphotriester approach: Controversial comments and complementary data. Int. Antiviral News 1, 100-102.
8. Gouyette, C., Neumann, J.M., Fauve, R., Huynh-Dinh, T., 1989. 6- and 1-Substituted mannosyl phosphotriesters as lipophilic macrophage-targeted carriers of antiviral nucleosides. Tetrahedron Lett. 30, 6019-6022.
9. Henin, Y., Gouyette, C., Schwartz, O., Debouzy, J.C., Neumann, J.M., Huynh Dinh, T., 1991. Lipophilic glycosyl phosphotriester derivatives of AZT: Synthesis, NMR transmembrane transport study and antiviral activity. J. Med. Chem. 34, 1830-1837.
10. McGuigan, C., Nicholls, S.R., O'Connor, T.J., Kinchington, D., 1990a. Synthesis of some novel dialkyl phosphate derivatives of 3′-modified nucleosides as potential anti-AIDS drugs. Antiviral Chem. Chemother. 1, 25-33.
11. McGuigan, C., O'Connor, T.J., Nicholls, S.R., Nickson, C., Kinchington, D., 1990b. Synthesis and anti-HIV activity of some novel substituted dialkyl phosphate derivatives of AZT and ddCyd. Antiviral Chem. Chemother. 1, 355-360.
12. McGuigan, C., Devine, K.G., O'Connor, T.J., Kinchington, D., 1991a. Synthesis and anti-HIV activity of some haloalkyl phosphoramidate derivatives of 3′-azido-3′-deoxythymidine (AZT): Potent activity of the trichloroethyl methoxyalaninyl compound. Antiviral Res. 15, 255-263.
13. McGuigan, C., Jones, B.C.N.M., Devine, K.G., Nicholls, S.R., O'Connor, T.J., Kinchington, D., 1991b. Attempts to introduce chemotherapeutic nucleotides into cells: Studies on the anti-HIV agent FdT. Bioorg. Med. Chem. Lett. 1, 729-732.
14. McGuigan, C., Pathirana, R.N., Mahmood, N., Devine, K.G., Hay, A.J., 1992. Aryl phosphate derivatives of AZT retain activity against HIV1 in cell lines which are resistant to the action of AZT. Antiviral Res. 17, 311-321.
15. McGuigan, C., Kinchington, D., Wang, M.F., Nicholls, S.R., Nickson, C., Galpin, S., Jeffries, D.J., O'Connor, T.J., 1993a. Nucleoside analogues previously found to be inactive against HIV may be activated by simple chemical phosphorylation. FEBS Lett. 322, 249-252.
16. McGuigan, C., Pathirana, R.N., Balzarini, J., De Clercq, E., 1993b. Intracellular delivery of big-active AZT nucleotides by aryl phosphate derivatives of AZT. J. Med. Chem. 36, 1048-1052.
17. McGuigan, C., Cahard, D., Sheeka, H.M., De Clercq, E., Balzarini, J., 1996a. Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolise. J. Med. Chem. 39, 1748-1753.
18. McGuigan, C., Cahard, D., Sheeka, H.M., De Clercq, E., Balzarini, J., 1996b. Phosphoramidate derivatives of d4T with improved anti-HIV efficacy retain full activity in thymidine kinase-deficient cells. Bioorg. Med. Chem. Lett. 6, 1183-1186.
19. McGuigan, C., Wedgwood, O.M., De Clercq, E., Balzarini, J., 1996c. Phosphoramidate derivatives of 2′,3′-didehydro-2′,3′-dideoxyadenosine (d4A) have markedly improved anti-HIV potency and selectivity. Bioorg. Med Chem. Lett. 6, 2359-2362.
20. McGuigan, C., Cahard, D., Salgado, A., De Clercq, E., Balzarini, J., 1996d. Phosphoramidates as potent pro-drugs of anti-HIV nucleotides: Studies in the amino region. Antiviral Chem. Chemother. 7, 31-36.
21. McGuigan, C., Salgado, A., Yarnold, C., Harries, T.Y., De Clercq, E., Balzarini, J., 1996e. Novel nucleoside phosphoramidates as inhibitors of HIV: Studies on the stereochemical requirements of the phosphoramidate amino acid. Antiviral Chem. Chemother. 7, 184-188.
22. Perigaud, C., Girardet, J.-L., Gosselin, G., Imbach, J.-L., 1996. Comments on nucleotide delivery forms. In: De Clercq, E., et al. (Eds.), Advances in Antiviral Drug Design, vol 2, JAI, Greenwich, CT, pp. 147-172 and references cited therein.